Trials / Conditions / Systemic Mastocytosis With an Associated Hematologic Neoplasm
Systemic Mastocytosis With an Associated Hematologic Neoplasm
3 registered clinical trials studyying Systemic Mastocytosis With an Associated Hematologic Neoplasm — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Avapritinib With Decitabine in Patients With SM-AHN NCT06327685 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Completed | (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted NCT03580655 | Blueprint Medicines Corporation | Phase 2 |
| No Longer Available | Managed Access Programs for PKC412, Midostaurin NCT05219266 | Novartis Pharmaceuticals | — |